论文部分内容阅读
目的:探究慢性支气管炎的临床疗效。方法:选取2014年3月-2015年3月100例慢性支气管炎患者,随机将其分为实验组和对照组。对照组给予常规止咳、抗感染等治疗,实验组在对照组基础上加以双黄连治疗。对实验组和对照组慢性支气管炎患者经不同方法治疗的效果比较分析。结果:实验组治疗有效率优于对照组(P<0.05),两组不良反应情况无太大区别(P>0.05)。结论:给予慢性支气管炎患者常规止咳、抗感染等基础上加以双黄连治疗,可取得较好的临床效果。
Objective: To investigate the clinical efficacy of chronic bronchitis. Methods: A total of 100 chronic bronchitis patients were selected from March 2014 to March 2015, and randomly divided into experimental group and control group. The control group was given routine cough and anti-infective therapy, and the experimental group was treated with Shuanghuanglian on the basis of the control group. The experimental group and control group of patients with chronic bronchitis by different methods of treatment of comparative analysis. Results: The effective rate of the experimental group was better than that of the control group (P <0.05). There was no significant difference between the two groups in adverse reactions (P> 0.05). Conclusion: The conventional treatment of chronic bronchitis cough, anti-infection on the basis of Shuanghuanglian treatment, can achieve better clinical results.